Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. (XKON:A216400) for KRW 10 billion on May 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,720 KRW | +1.40% | -2.57% | -6.24% |
1st Jan change | Capi. | |
---|---|---|
-6.24% | 49.44M | |
-31.06% | 9.41B | |
+27.31% | 2.9B | |
-14.31% | 2.16B | |
-18.94% | 1.7B | |
+73.13% | 1.51B | |
+30.25% | 814M | |
-1.97% | 760M | |
-26.73% | 529M | |
+5.17% | 312M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Healthcare Co., Ltd. agreed to acquire Invites Genomics Co., Ltd. from Invites Biocore Co., Ltd. for KRW 10 billion